Literature DB >> 628841

Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan.

P L Kokoshis, D L Williams, J A Cook, N R Di Luzio.   

Abstract

Glucan is a potent reticuloendothelial stimulant whose immunobiological activity is mediated, in part, by an increase in the number and function of macrophages. In studying the role of glucan as a mediator of antibacterial activity, we attempted to ascertain the ability of glucan to modify the mortality of mice with experimentally induced Gram-positive bacteremia, and to enhance antibacterial defenses in rats as denoted by serum lysozyme and phagocytic activity. After intravenous administration of glucan, serum lysozyme concentrations were increased approximately sevenfold over control concentrations. The increase in serum lysozyme appeared to parallel the glucan-induced increase in phagocytosis and induced hyperplasia of macrophages. Prior treatment of mice with glucan significantly enhanced their survival when they were challenged systemically with Staphylococcus aureus. These studies indicate that glucan confers an enhanced state of host defense against bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628841     DOI: 10.1126/science.628841

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  β-Glucan-induced reprogramming of human macrophages inhibits NLRP3 inflammasome activation in cryopyrinopathies.

Authors:  Giorgio Camilli; Mathieu Bohm; Alícia Corbellini Piffer; Rachel Lavenir; David L Williams; Benedicte Neven; Gilles Grateau; Sophie Georgin-Lavialle; Jessica Quintin
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 2.  Modification of diverse experimental immunosuppressive states by glucan.

Authors:  N R Di Luzio; D L Williams; E R Sherwood; I W Browder
Journal:  Surv Immunol Res       Date:  1985

3.  Immunostimulation. Clinical and experimental perspectives.

Authors:  J Drews
Journal:  Klin Wochenschr       Date:  1984-03-15

Review 4.  What's new in lysozyme research? Always a model system, today as yesterday.

Authors:  P Jollès; J Jollès
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

5.  Induction of natural killer cell activity by inactivated Candida albicans in mice.

Authors:  P Marconi; L Scaringi; L Tissi; M Boccanera; F Bistoni; E Bonmassar; A Cassone
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Development, characterization, and technical applications of a fish lysozyme-specific monoclonal antibody (mAb M24-2).

Authors:  Marlee B Marsh; Charles D Rice
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2009-11-08       Impact factor: 2.268

7.  Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.

Authors:  A B Onderdonk; R L Cisneros; P Hinkson; G Ostroff
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Glucan as an adjuvant for a murine Babesia microti immunization trial.

Authors:  J L Benach; G S Habicht; T W Holbrook; J A Cook
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism.

Authors:  L Håkansson; R Hällgren; P Venge
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum.

Authors:  Ming-Jen Hsu; Shiuh-Sheng Lee; Sho Tone Lee; Wan-Wan Lin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.